|
David Addis’s practice encompasses US foreign trade controls, including export controls, technology controls and encryption regulation, and antitrust counseling on mergers and acquisitions, joint ventures and other competitor collaborations, and intellectual property licensing, including IP licensing policies for standard-setting organizations.
Mr. Addis has extensive experience with US foreign trade controls, export regulations and embargo sanctions administered by the Departments of Commerce, Treasury, State and Homeland Security, and advises on compliance, obtaining licensing, and responding to possible enforcement actions. He advises on encryption regulations, compliance with export regulations for dual-use commercial products as well as defense articles and technology, and cross-border technology transfers in the computer, software and biotechnology sectors. He advises as well on embargo regulations and economic sanctions to combat terrorism, including help to obtain licensing for medical sales to embargoed countries.
Mr. Addis also provides antitrust counseling and transaction planning for mergers and acquisitions, joint ventures and collaborations; intellectual property licensing and cross-licensing agreements; and standards-setting activities. He has extensive experience advising clients on all aspects of complying with the Hart-Scott-Rodino (HSR) Act and regulations. He has represented Microsoft in its participation in a wide range of technical standards setting organizations, advising the company on intellectual property licensing policies and antitrust concerns agreements related to technical standards development.
Representative Matters
- Antitrust clearance for mergers, acquisitions, and license grants under the HSR review process before the Federal Trade Commission and the Justice Department’s Antitrust Division.
- Assisting global high-technology companies with export controls affecting encryption items and high-performance computers.
- Representing participants in two different biotechnology cross-licensing and collaboration joint ventures to develop and commercialize gene-based therapies, one investigated under the HSR process by the Federal Trade Commission and one by the Justice Department’s Antitrust Division, and successfully persuading both agencies to close the initial investigations without a challenge.
- Securing export licenses enabling leading pharmaceutical companies to sell medical products to embargoed countries, including Cuba, Iran, Iraq, Libya, and Sudan.
Pro Bono
- Amicus briefs in the Courts of Appeal on behalf of the Electronic Privacy Information Center in Junger v. Daly and Bernstein v. Department of State establishing that software source code is expression entitled to full First Amendment protection.
Publications and Speeches
- Antitrust Litigation Seminar, University of Virginia Law School, teaching with other firm lawyers (1995-2001)
|
|